Samenvatting
Verhoogde impulsiviteit is een kernsymptoom in verschillende psychiatrische en neurologische aandoeningen en wordt gekenmerkt door verstoringen in cognitieve controle en impulsieve beslissingen. Naast nieuwe toepassingen en mogelijkheden in humaan neuroimagingonderzoek, heeft vooral translationeel preklinisch onderzoek veel opgehelderd over de neurobiologie van impulsiviteit. Farmacologische interventies hebben het belang laten zien van de neurotransmitters serotonine, dopamine en noradrenaline in het reguleren van impulsief gedrag. De intrede van zeer geavanceerde technologieën in de neurowetenschappen, zoals de optogenetica en farmacogenetica, stelt ons in staat om grote sprongen voorwaarts te maken in het ontrafelen van de neurobiologie van impulsiviteit.
Literatuur
Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160:636–45.
Linnoila M, Virkkunen M, Scheinin M, et al. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci. 1983;33:2609–14.
Buckholtz JW, Treadway MT, Cowan RL, et al. Dopaminergic network differences in human impulsivity. Science. 2010;329:532.
Wiskerke J, Schetters D, Van Es IE, et al. µ-Opioid receptors in the nucleus accumbens shell region mediate the effects of amphetamine on inhibitory control but not impulsive choice. J Neurosci. 2011;31:262–72.
Wiskerke J, Stoop N, Schetters D, et al. Cannabinoid CB1 receptor activation mediates the opposing effects of amphetamine on impulsive action and impulsive choice. PLoS One. 2011;6:e25856.
Pattij T, Schetters D, Schoffelmeer AN, et al. On the improvement of inhibitory response control and visuospatial attention by indirect and direct adrenoceptor agonists. Psychopharmacology (Berl). 2012;219:327–40.
Wachter SB, Gilbert EM. Beta-adrenergic receptors, from their discovery and characterization through their manipulation to beneficial clinical application. Cardiology. 2012;122:104–12.
Steinberg EE, Christoffel DJ, Deisseroth K, et al. Illuminating circuitry relevant to psychiatric disorders with optogenetics. Curr Opin Neurobiol. 2015;30:9–16.
Saddoris MP, Sugam JA, Stuber GD, et al. Mesolimbic dopamine dynamically tracks, and is causally linked to, discrete aspects of value-based decision making. Biol Psychiatry. 2015;77:903–11.
Friedman A, Homma D, Gibb LG, et al. A corticostriatal path targeting striosomes controls decision-making under conflict. Cell. 2015;161:1320–33.
Urban DJ, Roth BL. DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility. Annu Rev Pharmacol Toxicol. 2015;55:399–417.
Koike H, Demars MP, Short JA, et al. Chemogenetic inactivation of dorsal anterior cingulate cortex neurons disrupts attentional behavior in mouse. Neuropsychopharmacology. 2015.doi:10.1038/npp.2015.229.
Ward RD, Winiger, V, Kandel ER, et al. Orbitofrontal cortex mediates the differential impact of signaled-reward probability on discrimination accuracy. Front Neurosci. 2015;9:230.
Krack P, Hariz MI, Baunez C, et al. Deep brain stimulation: from neurology to psychiatry? Trends Neurosci. 2010;33:474–84.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pattij, T. Mechanismen van impulsiviteit in neurologie en psychiatrie: recente ontwikkelingen in translationeel preklinisch onderzoek. Neuroprax 20, 45–50 (2016). https://doi.org/10.1007/s12474-015-0111-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12474-015-0111-2